Loading
Latest filing published 08 Jan 2019 for Regenerx Biopharmaceuticals INC, €28k.
No signal scores available.
Joseph C. Mcnay discloses dealings in Regenerx Biopharmaceuticals Inc to SEC (Form 4). In total, 4 filings cover trades dated from 29 March 2018 to 6 January 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 8 January 2019 with a transaction (€28k) in Regenerx Biopharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations